SUMMARY Gastric secretory dose-response studies, using an 8.5 % mixed L-amino acid solution as the agonist, were carried out in three dogs with Heidenhain pouches and gastric fistulae. Secretory responses of the Heidenhain pouches were measured during two hour infusions of amino acids given at rates of 0, 0.05, 0.1, 0-2, 0.4, 0.8, and 1.6 g/kg/h and plasma amino nitrogen was measured before and during the infusion. 4 September 1979 were performed aseptically with the dogs fully anaesthetised, and a recovery period of three to four weeks was allowed before secretory studies were undertaken. The studies were carried out after an 18 hour fast, during which water was allowed, and were repeated no more often than thrice weekly. With the dogs in modified Pavlov stands, an intravenous solution of 0.9% NaCI was begun. Secretion from the pouches was collected each 30 minutes and the H+ion content was determined; secretion from the main stomach was allowed to drain externally and was discarded. After a basal collection period of 60 minutes the test solution was administered by a peristaltic pump at a constant infusion rate for two hours. The test solution consisted of an 8.5% solution of mixed L-amino acids (Freamine II, McGaw Laboratories) given at a dose of 0.05, 0.1. 0.2, 0.4, 0.8, or 1.6 g/kg/h or of a solution of 0.9% sodium chloride (control) given at 30 ml/h. Only one dose was given on each test day and the order in which the various doses was given was randomised. Three tests at each dose, as well as three control infusions, were made in each dog. Blood was taken during the basal period and at 30 and 90 minutes after start of the test infusion. After centrifugation, the plasma was frozen and stored at -20C for subsequent amino nitrogen determinations by the method of Goodwin.7
The question whether amino acids would stimulate gastric secretion directly has been a long-standing one. Evidence, until 4 September 1979 were performed aseptically with the dogs fully anaesthetised, and a recovery period of three to four weeks was allowed before secretory studies were undertaken. The studies were carried out after an 18 hour fast, during which water was allowed, and were repeated no more often than thrice weekly. With the dogs in modified Pavlov stands, an intravenous solution of 0.9% NaCI was begun. Secretion from the pouches was collected each 30 minutes and the H+ion content was determined; secretion from the main stomach was allowed to drain externally and was discarded. After a basal collection period of 60 minutes the test solution was administered by a peristaltic pump at a constant infusion rate for two hours. The test solution consisted of an 8.5% solution of mixed L-amino acids (Freamine II, McGaw Laboratories) given at a dose of 0.05, 0.1. 0.2, 0.4, 0.8, or 1.6 g/kg/h or of a solution of 0.9% sodium chloride (control) given at 30 ml/h. Only one dose was given on each test day and the order in which the various doses was given was randomised. Three tests at each dose, as well as three control infusions, were made in each dog. Blood was taken during the basal period and at 30 and 90 minutes after start of the test infusion. After centrifugation, the plasma was frozen and stored at -20C for subsequent amino nitrogen determinations by the method of Goodwin.7
When the dose which gave the maximum response had been determined, a second series of experiments was carried out to ensure that hyperosmolarity of 91 the test solution had not altered the secretory response. Tests were performed in the same way as those described above but with the single dose of 0.4g/kg/h given either as the 8-5% solution (850 mOsm/l) or as a 3% solution (300 mOsm/l). rise and acid secretion up to the dose which produced maximum secretion (correlation coefficient, r=0.65; P<0-05). Above this level, although there was a sharp increase in amino nitrogen, there was no further rise in acid output.
When the secretory response to 0.4 g/kg/h of amino acids given as a 3% solution was compared with that to the same dose given as an 8.5% solution, there was no significant difference (P>0.45), as seen in Fig. 2 . With both solutions, significant inhibition of the secretory response to amino acids occurred when acid secretion from the main stomach was allowed to enter the duodenum by closure of the gastric fistula (p<0 01 in each case).
Discussion
It is apparent from these studies that a solution of mixed L-amino acids acts as a gastric secretagogue in a fashion not dissimilar from that of the more widely studied histamine and gastrin.8 '9 These agents have in common the fact that larger doses are associated with greater secretory responses to a certain dose level, beyond which an increase in dose is associated either with no further rise or with an actual decrease in secretory response. Because the amino acid solution used is capable of stimulating gastric secretion to a level no greater than 20% of that seen with maximal histamine stimulation, it must be considered to be a relatively weak gastric agonist.
The hyperosmolarity of the solution apparently had no effect on gastric secretion, for identical group.bmj.com on June 3, 2017 -Published by http://gut.bmj.com/ Downloaded from secretory responses were obtained at the maximally effective dose whether an isosmotic or hyperosmotic solution were given. Furthermore, the physiological inhibition of gastric secretion which takes place when acid from the stomach is allowed to flow into the duodenum (gastric fistula closed) was equally effective with both solutions.
Interest in amino acids as possible agonists for gastric secretion stems largely from the fact that they may be involved in the mediation of the intestinal phase of gastric secretion, which is activated by the presence of protein in the small bowel. Frame"' has shown that a 60 g protein meal in man is accompanied by mean rises of approximately 11 to 1 4 mmol/l (I 5 to 2-0 mg%) in plasma amino nitrogen. An increase in plasma amino nitrogen of this magnitude in our experiment evoked gastric *secretion in the range of about 3 to 5% of the maximal histamine response. Thus, it seems likely that amino acids, absorbed into the gut, account for a significant proportion of intestinal phase secretion.
Whether or not amino acids contribute appreciably to the intestinal phase of gastric secretion, their current widespread use for the nutritional support of patients whose caloric needs cannot be supplied via the gastrointestinal tract makes their gastric secretory effect of interest to clinicians. At rates of administration generally used clinically in man, the secretory response of the dogs was no higher than 3% of the maximal histamine response, a level of secretion that is probably not high enough to be a cause for concern. 
